Daily Newsletter

01 November 2023

Daily Newsletter

01 November 2023

New ADHD clinic launched in Newcastle, NSW

This initiative is expected to alleviate the general paediatric waitlist and offer specialised care for patients.

November 01 2023

A new clinic has been set up in Newcastle, New South Wales (NSW), Australia, to provide increased support for children aged six to 12 years with attention deficit hyperactivity disorder (ADHD).

The clinic aims to offer timely diagnosis and treatment for ADHD, which affects around one in 20 children in the state.

This initiative is expected to alleviate the general paediatric waitlist and offer specialised care for patients.

It follows a shared-care model, allowing ongoing management between a paediatrician and the patient's regular general practitioner (GP) and reducing the need for patients to travel to hospitals for follow-up care.

In addition to providing in-person services in Newcastle, the clinic will support rural and regional patients through virtual services.

The multidisciplinary team at the clinic includes paediatricians, a psychologist, a clinical nurse consultant, pharmacist, an Aboriginal health worker, a shared care coordinator, and administration staff.

This initiative is said to be the result of an A$7.7m ($4.88m) investment over four years from the NSW government. The plan is to run the clinic as a pilot project for the next two years.

Hunter New England local health district executive director for children, young people and families Dr Paul Craven said: “We work with the patient, their family and support networks, as well as a team of clinicians to provide individualised assessment and diagnosis before aiming to share care with the family GP and local specialist.

“It allows patients to stay closer to home for their follow-up care, which is particularly important for our regional and rural patients and will allow families to continue building strong relationships with their existing GPs.

“As the service grows, we’ll also look to provide outreach clinics to areas where there is the greatest need and will continue to leverage our growing telehealth and virtual care offerings when appropriate.”

Is the healthcare industry ready to fully embrace the benefits of digitalization and AI?

The healthcare, pharma, and medical devices industries are often risk-averse compared to other sectors when adopting new technologies. However, mainly due to COVID-19, these sectors have witnessed an acceleration in digital transformation. AI can revolutionize the drug discovery process and significantly reduce the time and cost to get a drug to market, particularly in areas of unmet need. There is also huge potential for AI in medical diagnostics. However, using healthcare data for AI development raises data privacy concerns, thereby limiting its adoption.

Newsletters by sectors

close

Sign up to the newsletter: In Brief

Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Thank you for subscribing

View all newsletters from across the GlobalData Media network.

close